The economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders

Journal of Substance Abuse Treatment

Volumn 41, Issue 2, 2011, Pages 201-207

  Dennis, Michael L ^a   French, Michael T ^b,c   McCollister, Kathryn E ^c   Scott, Christy K ^a  

^a CHESTNUT HEALTH SYSTEMS   (United States)

^b Department of Biology   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Controlled clinical trial; Economic cost; Recovery management; Substance abuse treatment

Indexed keywords

ADULT; ARTICLE; CONSULTATION; CONTROLLED STUDY; CONVALESCENCE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; ECONOMIC EVALUATION; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME MONITORING; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOVERY MANAGEMENT CHECKUP; RELAPSE; SOCIETY; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; RECURRENCE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960647293     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.02.007     Document Type: Article

References (59)

1. American Hospital Association Handbook for hospital billing 2005, AHA, Chicago, IL.
2. Anglin M.D., Hser Y.I. Treatment of drug abuse. Crime and Justice 1990, 13:393-460.
3. Baumohl J., Speiglman R., Swartz J.A., Stahl R. Substance abuse and welfare policy at the new century. Contemporary Drug Problems 2003, 30:501-537.
4. Cartwright W.S. Brief data report: Cost of drug abuse to society. The Journal of Mental Health Policy and Economics 1999, 2:133-134.
5. Cartwright W.S. Cost-Benefit analysis of drug treatment services: Review of the literature. The Journal of Mental Health Policy and Economics 2000, 3:11-26.
6. Cartwright W.S. Economic costs of drug abuse: Financial, cost of illness, and services. Journal of Substance Abuse Treatment 2008, 34:224-233.
7. Caulkins J.P. Measurement and analysis of drug problems and drug control efforts. Criminal Justice 2000, 4:391-449.
8. Caulkins J.P., Everingham S.S., Rydell C.P., Chiesa J., Bushway S. An ounce of prevention, a pound of uncertainty: The cost-effectiveness of school-based drug prevention programs 1999, RAND Corporation, Santa Monica, CA.
9. Cook P.J., Moore M.J. This tax's for you: The case for higher beer taxes. National Tax Journal 1994, 47:559-573.
10. Currie J., Madrian B.C. Health, health insurance, and the labor market. Handbook of labor economics, Vol. 3 1999, 3309-3416. Elsevier Science, New York, NY. O. Ashenfelter, D. Card (Eds.).
11. Dennis M.L., Godley S.H., Diamond G., Tims F.M., Babor T., Donaldson J., et al. The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials. Journal of Substance Abuse Treatment 2004, 27:197-213.
12. Dennis M.L., Scott C.K. Managing addiction as a chronic condition. Addiction Science & Clinical Practice 2007, 4:45-55.
13. Dennis M.L., Scott C.K., Funk R. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning 2003, 26:339-352.
14. Dennis M.L., Titus J.C., White M., Unsicker J., Hodgkins D. Global Appraisal of Individual Needs (GAIN): Administration guide for the GAIN and related measures 2003, Chestnut Health Systems, Bloomington, IL, Available online at: http://www.chestnut.org/li/gain. Accessed June 7, 2010.
15. Drummond M.F., O'Brien B.J., Stoddart G.L., Torrance G.W. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, Oxford, England. 3rd ed.
16. Fleming M.F., Mundt M.P., French M.T., Manwell L.B., Stauffacher E.A., Barry K.L. Benefit-Cost analysis of brief physician advice with problem drinkers in primary care settings. Medical Care 2000, 38:7-18.
17. Foster E.M., Dodge K.A., Jones D. Issues in the economic evaluation of prevention programs. Applied Developmental Science 2003, 7:76-86.
18. French M.T. DATCAP-Drug Abuse Treatment Cost Analysis Program (DATCAP): Program version 2003, University of Miami, Coral Gables, FL, Available online at: http://www.datcap.com. Accessed June 10, 2010.
19. French M.T., Drummond M.C. A research agenda for economic evaluation of substance abuse services. Journal of Substance Abuse Treatment 2005, 29:125-137.
20. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 1997, 14:445-455.
21. French M.T., Homer J.F., Nielsen A.L. Does America spend enough on addiction treatment? Results from public opinion surveys. Journal of Substance Abuse Treatment 2006, 31:245-254.
22. French M.T., McGeary K.A. Estimating the economic cost of substance abuse treatment. Health Economics 1997, 6:539-544.
23. French M.T., Popovici I., Tapsell L.M. The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement. Journal of Substance Abuse Treatment 2008, 35:462-469.
24. Garber A.M., Phelps C.E. Economic foundations of cost-effectiveness analysis. Journal of Health Economics 1997, 16:1-31.
25. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine 1996, Oxford University Press, New York, NY.
26. Harwood H., Fountain D., Livermore G. Economic costs of alcohol and drug abuse in the United States, 1992 1998, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, Department of Health and Human Services, NCJRS, Rockville, MD.
27. Harwood H., Fountain D., Livermore G. The economic costs of alcohol and drug abuse in the United States, 1992. Addiction 1999, 94:631-647.
28. Holder H. Cost benefits of substance abuse treatment: An overview of results from alcohol and drug abuse. Journal of Mental Health Policy and Economics 1998, 1:23-29.
29. Kerr T., Small W., Wood E. The public health and social impacts of drug market enforcement: A review of the evidence. International Journal of Drug Policy 2005, 16:210-220.
30. Koeing L., Siegel J.M., Harwood H., Gilani J., Chen Y.J., Leahy P., et al. Economic benefits of substance abuse treatment: Findings from Cuyhoga County, Ohio. Journal of Substance Abuse Treatment 2005, 28:S41-S50.
31. Kymalainen J.A., Weisman A. Reactions toward mental, physical, and substance-abuse disorders. Journal of Applied Social Psychology 2004, 34:1883-1899.
32. Leshner A.I. Addiction is a brain disease, and it matters. Science 1997, 278:45-47.
33. McCollister K.E., French M.T. The relative contribution of outcome domains in the total economic benefit of addition interventions: A review of first findings. Addiction 2003, 98:1647-1659.
34. McCollister K.E., French M.T., Fang H. The cost of crime to society: New crime-specific estimates for policy and program evaluation. Drug and Alcohol Dependence 2010, 108:98-109.
35. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
36. McKay J.R. Effectiveness of continuing care interventions for substance abusers. Evaluation Review 2001, 25:211-232.
37. McKay J.R. Is there a case for extended interventions for alcohol and drug use disorders?. Addiction 2005, 100:1594-1610.
38. Miller T.R., Levy D.T., Cohen M.A., Cox K.L. Costs of alcohol and drug-involved crime. Prevention Science 2006, 7:333-342.
39. Miller W.R. Motivational interviewing: IV. Some parallels with horse whispering. Behavioural and Cognitive Psychotherapy 2000, 28:285-292.
40. Mullahy J., Sindelar J.L. Health, income, and risk aversion. Journal of Human Resources 1995, 30:439-459.
41. Office of National Drug Control Policy National drug control strategy, 2010 2010, ONDCP, Washington, DC, Available online at: http://www.whitehousedrugpolicy.gov/publications/policy/ndcs10/ndcs2010.pdf. Accessed June 7, 2010.
42. Pelletier K.R. A review and analysis of the critical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update. American Journal of Health Promotion 2001, 16:107-116.
43. Pelletier K.R. A review and analysis of the critical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: Update VI 2000-2004. Journal of Occupational and Environmental Medicine 2005, 47:1051-1058.
44. Popovici I., French M.T., McKay J. Economic evaluation of continuing care interventions in the treatment of substance abuse: Recommendations for future research. Evaluation Review 2008, 32:547-568.
45. Rajkumar A.S., French M.T. Drug abuse, crime costs, and the economic benefits of treatment. Journal of Quantitative Criminology 1997, 13:291-323.
46. Rice D.P. Economic costs of substance abuse, 1995. Proceedings of the Association of American Physicians 2003, 111:119-125.
47. Roebuck M.C., French M.T., McLellan A.T. DATStats: Results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 2003, 25:51-57.
48. Room R. Stigma, social inequality and alcohol and drug use. Drug and Alcohol Review 2005, 24:143-155.
49. Rosen S.M., Miller T.R., Simon M. The cost of alcohol in California. Alcoholism Clinical and Experimental Research 2008, 32:1925-1936.
50. Rush B.R., Dennis M.L., Scott C.K., Castel S., Funk R.R. The interactions of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery. Evaluation Review 2008, 32:7-38.
51. Scott C.K. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug and Alcohol Dependence 2004, 74:21-36.
52. Scott C.K., Dennis M.L. Recovery Management Checkups: An early re-intervention model 2003, Chestnut Health Systems, Chicago, IL, Available online at: http://www.chestnut.org/LI/downloads/Scott_&_Dennis_2003_RMC_Manual-2_25_03.pdf. Accessed June 10, 2010.
53. Scott C.K., Dennis M.L. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction 2009, 104:959-971.
54. Scott C.K., Dennis M.L. Recovery management checkups with adult chronic substance users. Addiction recovery management: Theory, research, and practice 2011, 87-101. Springer, New York, NY. J.F. Kelly, W.L. White (Eds.).
55. Scott C.K., Dennis M.L., Foss M.A. Utilizing recovery management checkups to shorten the cycle of relapse, treatment re-entry, and recovery. Drug and Alcohol Dependence 2005, 78:325-338.
56. Scott C.K., Sonis J., Creamer M., Dennis M.L. Maximizing follow-up in longitudinal studies of traumatized populations. Journal of Traumatic Stress 2006, 19:757-769.
57. Sherman B. Worksite health promotion-A critical investment. Disease Management & Health Outcomes 2002, 10:101-108.
58. Substance Abuse and Mental Health Services Administration (SAMHSA) Substance abuse prevention dollars and cents: A cost benefit analysis. (DHHS [SMA] Publication No. 07-4298) 2009, Center for Substance Abuse Prevention (CSAP), SAMHSA.
59. Zavala S.K., French M.T., Henderson C.E., Alberga L., Rowe C., Liddle H.A. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments. Journal of Substance Abuse Treatment 2005, 29:191-205.